Author/Authors :
-، - نويسنده Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Aghebati, Tamara , -، - نويسنده Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Mohammadpour, Amir Hooshang , -، - نويسنده Department of Anatomy, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran|Medical Toxicology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran Afshar, Mohammad , -، - نويسنده Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Jaafari, Mahmoud Reza , -، - نويسنده Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Abnous, Khalil , -، - نويسنده Research and Education Department, Razavi Hospital, Mashhad, Iran Nazemi, Saeed , -، - نويسنده Research and Education Department, Razavi Hospital, Mashhad, Iran Issazadeh, Sobhan , -، - نويسنده Research and Education Department, Razavi Hospital, Mashhad, Iran Hashemzadeh, Saeed , -، - نويسنده Hefdahe Shahrivar Hospital, Mashhad, Iran Zare, Mohammad , -، - نويسنده Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran Badiee, Ali
Abstract :
Objective(s): In this study, for the first time, MF59 adjuvant was used to develop a cholesteryl ester transfer protein (CETP) vaccine. The efficacy of the vaccine was compared with the efficacy of CETP vaccine formulated with Alum/CpG, the formulation that its immunogenicity has been already demonstrated in rabbit and mice. Materials and Methods: Tetanus toxoid- CETP peptide (TT-CETP) was mixed with Alum/CpG or MF59-like and administered subcutaneously for total five times in rabbit model of atherosclerosis. Anti-TT-CETP specific antibody, CETP activity in sera and mRNA level of cytokine IL-4 and IFN-γ in peripheral mononuclear cells were determined. Therapeutic response was also examined by tracking serum lipoprotein levels and pathologic observation of atherosclerotic lesions at aortic site. Results: More anti-TT-CETP antibody was found in Alum/CpG vaccinated rabbits compared to buffer (P<0.001). Antibody induced by MF59-like formulation was not significantly higher than buffer. CETP activity and lipoprotein levels were not significantly different between vaccinated and control rabbits. The mRNA level of IL-4 was significantly lower than buffer while, IFN-γ gene expression was significantly higher in both vaccinated groups. Atherosclerosis thickness grade of aorta was dramatically lower than buffer (P<0.01) in both vaccinated groups. Conclusion: It is concluded that MF59-adjuvanted CETP vaccine showed anti-atherosclerosis properties, but the protective effect could not be directly attributed to the immune response induced by anti TT-CETP antibody and CETP inhibition. Further studies are needed to explain the anti-atherosclerosis properties of MF59 in the presence of TT-CETP peptide.
